What drugs does CONTRACT PHARMACAL make?

CONTRACT PHARMACAL has 12 FDA-approved drugs.

What therapeutic areas does CONTRACT PHARMACAL focus on?

CONTRACT PHARMACAL focuses primarily on Immunology and Gastroenterology.

← Back

Data updated: Jun 28, 2026

CONTRACT PHARMACAL

Generics

Immunology Gastroenterology

CONTRACT PHARMACAL is a generic drug manufacturer focused on Immunology, Gastroenterology.

1972

Since

Drugs

Trials

New Drugs (2yr)

Modality:

1 Small Molecules

CONTRACT PHARMACAL's Key Drugs

CONTRACT PHARMACAL's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

CONTRACT PHARMACAL's Recent FDA Approvals

CONTRACT PHARMACAL secured 1 new FDA approval for novel drugs (NDA/BLA) in the last two years.

FAMOTIDINE NDA

2025-07-16

famotidine

1 INDICATIONS AND USAGE Famotidine tablets are indicated in adult and pediatric patients 40 kg and greater for the treatment of: • active duodenal ulcer (DU). • active gastric ulcer (GU). • symptomatic nonerosive gastroesophageal reflux disease (GERD). • erosive esophagitis due to GERD, diagnosed by biopsy. Famotidine tablets are indicated in adults for the: • treatment of pathological hypersecretory conditions (e.g., Zollinger-Ellison syndrome, multiple endocrine neoplasias). • reduction of the risk of duodenal ulcer recurrence. Famotidine tablets are a histamine-2 (H 2 ) receptor antagonist indicated ( 1 ): In adult and pediatric patients 40 kg and greater for the treatment of: • active duodenal ulcer (DU). • active gastric ulcer. • symptomatic nonerosive gastroesophageal reflux disease (GERD). • erosive esophagitis due to GERD, diagnosed by biopsy. In adults for the: • treatment of pathological hypersecretory conditions (e.g., Zollinger-Ellison syndrome, multiple endocrine neoplasias). • reduction of the risk of DU recurrence.

CONTRACT PHARMACAL's Therapeutic Areas

CONTRACT PHARMACAL's approved drugs and pipeline span 2 therapeutic areas, led by Immunology and Gastroenterology, across 0 biologic and 1 small-molecule drug. Weighted by commercial stage — approved drugs count most, then late-stage trials.

Immunology 50%

1 drugs

Gastroenterology 50%

1 drugs

CONTRACT PHARMACAL's Top Competitors

CONTRACT PHARMACAL's closest competitors by therapeutic-area and drug-target overlap include Johnson & Johnson, Bristol-Myers Squibb, and BAUSCH. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.

Johnson & Johnson big-pharma

Immunology, Gastroenterology

Bristol-Myers Squibb big-pharma

Immunology, Gastroenterology

BAUSCH specialty

Immunology, Gastroenterology

Takeda big-pharma

Immunology, Gastroenterology

PF PRISM CV big-pharma

Immunology, Gastroenterology